Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI eye test: could a computer replace your eye doctor?

NCT ID NCT07096232

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares a new AI system, called AEYE, against a human eye doctor in diagnosing keratoconus and deciding who is eligible for laser vision correction. The AI analyzes patient history, eye scans, and other data to make its recommendations. Researchers will check if the AI is as accurate and reliable as the doctor, using 50 real patient cases.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multi-Agent AI Diagnostic Workflow (AEYE)
What this could lead to
If successful, this AI system could help eye doctors make faster, more accurate diagnoses of keratoconus and better decide who is safe for laser eye surgery.
What could go wrong
This is a small, early-stage study with only 50 cases, so results may not apply to all patients. The AI might not perform as well in real-world, diverse settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Sep 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study includes 50 anonymized patient cases collected from a private ophthalmology clinic. Patients were originally evaluated either for refractive surgery-including LASIK or other vision correction procedures-or for suspected or known keratoconus. Each case includes complete clinical documentation and high-quality corneal imaging (e.g., Pentacam, AS-OCT). The study population represents a typical clinical spectrum, including normal eyes, early or forme fruste keratoconus, post-CXL, and post-keratoplasty cases. All data was de-identified and retrospectively analyzed to assess the diagnostic performance of the AEYE system against expert human evaluation.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosis of Refractive Error or Keratoconus: * Patients with a confirmed clinical diagnosis of refractive errors (myopia, hyperopia, or astigmatism) or keratoconus, as determined by a qualified ophthalmologist based on current diagnostic standards. 2. Availability of Complete Data: * Clinical records must include comprehensive demographic data, medical and ophthalmic history, refraction measurements, and high-quality corneal imaging (e.g., corneal topography, tomography, or OCT). 3. Eligible for Both AI and Consultant Review: * Patients must have data sets that allow both the multi-agent AI workflow (AEYE) and an independent consultant ophthalmologist to conduct a complete diagnostic assessment. 4. Consent: * For prospectively enrolled patients, written informed consent must be obtained prior to participation. For retrospective cases, waiver of consent may be granted according to local IRB/ethics committee policies. 5. No Restriction on Age or Sex: * There are no specific age or sex limitations for inclusion in this study. Pediatric and adult cases may be included if data are available and consent is appropriately obtained. Clinical Documentation Requirements: * Availability of complete ophthalmic records including: * Uncorrected and best corrected visual acuity (UCVA, BCVA) * Manifest refraction (sphere, cylinder, axis) * History of contact lens use and duration * Prior ocular surgery or trauma, if applicable * Family history of keratoconus or corneal ectasia * Use of medications that may influence tear film stability or corneal biomechanics * Ocular surface disease documentation if present (e.g., dry eye, blepharitis) Imaging and Diagnostic Data Requirements: * Availability of at least one valid and complete set of: * Scheimpflug-based corneal tomography (e.g., Pentacam or equivalent) * Anterior segment OCT (AS-OCT), if performed * Epithelial thickness mapping (optional but desirable) * Corneal biomechanical data (optional) * Imaging files must be: * Of adequate quality as judged by the original technician and reviewer * Free from significant artifacts or motion blur * Properly labeled by eye (OD/OS) and imaging modality * Acquired with standard scan protocols Diagnostic Spectrum Requirements: * Patients may fall into any of the following diagnostic categories: * Normal cornea eligible for laser refractive surgery * Suspect keratoconus or forme fruste keratoconus * Established keratoconus of any stage (I-IV or ABCD) * Post-CXL (cross-linking) cornea undergoing follow-up evaluation * Post-keratoplasty cornea (e.g., DALK, PKP) undergoing diagnostic review * Patients disqualified from surgery due to abnormal tomography or other contraindications. Exclusion Criteria: 1. Incomplete or Poor Quality Data: * Patients with missing, incomplete, or poor-quality clinical data or corneal imaging that precludes reliable diagnosis by either AI or consultant review. 2. Ocular Comorbidities: * Presence of ocular diseases that could confound the diagnosis or interpretation of refractive error or keratoconus, such as advanced glaucoma, active uveitis, significant retinal pathology, or previous corneal transplantation. 3. Severe Systemic Disease Affecting the Eye: * Patients with systemic diseases known to affect the cornea or refraction (e.g., connective tissue disorders with corneal involvement) will be excluded to avoid confounding effects. 4. Inability or Refusal to Consent: * For prospectively enrolled cases, patients (or guardians, in the case of minors) who are unwilling or unable to provide informed consent will be excluded. 5. Participation in Conflicting Studies: * Patients currently enrolled in other interventional studies that could interfere with the diagnostic process or outcomes measured in this study. Clinical Documentation Exclusions: * Missing or incomplete visual acuity data. * Absence of manifest refraction or subjective refraction data. * Incomplete or conflicting patient history with unresolvable discrepancies. * Absence of necessary demographic identifiers (e.g., gender, age, laterality of findings). Imaging and Data Quality Exclusions: * Imaging datasets with significant artifacts that preclude AI analysis. * Files missing key parameters (e.g., Belin/Ambrósio D index, Kmax, pachymetry) required for keratoconus classification. * Inability to determine laterality (OD/OS) for specific scans. * Scans acquired with outdated or non-standard imaging protocols. * Mislabeling or duplication of imaging sets across different patients. Case-Type Exclusions: * Cases involving active ocular infection or inflammation at the time of evaluation. * Cases with active herpetic eye disease, corneal ulcer, or epithelial defects interfering with imaging interpretation. * Prior laser refractive surgery unless explicitly classified and used as part of post-refractive ectasia evaluation. * Eyes with concurrent advanced retinal pathology that may confound diagnostic interpretation (e.g., macular edema, retinal dystrophies). Technology-Specific Exclusions: * Imaging performed using devices not compatible with the AEYE data ingestion framework (e.g., certain older corneal topographers). * Non-English documentation incompatible with NLP parsing in the General Ophthalmology Agent. Other Considerations: * AEYE must be able to process the case within its defined schema. If key data elements are absent or the case causes schema failure, it will be excluded from quantitative analysis but may be reported qualitatively as part of system performance limitations. * If multiple attempts at AI processing result in non-deterministic or erroneous outputs, such cases will be logged but excluded from primary outcome evaluation. * Human reviewers (consultant ophthalmologists) must have completed their diagnostic interpretation independently prior to AEYE input; any cases where human opinion was influenced by AI output will be excluded to preserve blinding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artifical intelligence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hazem Yassin Clinics

    Cairo, Maadi, 11728, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.